down arrow

Jilin Aodong Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000719
  • SHE: 000623
CNY
17.48
-0.25 (-1.41%)

Sep 24

SHE

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Jilin Aodong Pharmaceutical Group Co., Ltd.

Why is Jilin Aodong Pharmaceutical Group Co., Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of -0.61% and Operating profit at -207.59% over the last 5 years
2
Flat results in Mar 26
  • INTEREST(HY) At CNY 30.97 MM has Grown at 46.48%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 1.21 times
  • NET SALES(Q) At CNY 514.09 MM has Fallen at -17.43%
3
With ROE of 8.49%, it has a very attractive valuation with a 0.61 Price to Book Value
  • Over the past year, while the stock has generated a return of 8.39%, its profits have risen by 39% ; the PEG ratio of the company is 0.2
  • At the current price, the company has a high dividend yield of 3
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Jilin Aodong Pharmaceutical Group Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jilin Aodong Pharmaceutical Group Co., Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Jilin Aodong Pharmaceutical Group Co., Ltd.
-8.43%
1.18
27.43%
China Shanghai Composite
0.9%
1.20
14.07%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-0.61%
EBIT Growth (5y)
-207.59%
EBIT to Interest (avg)
-1.62
Debt to EBITDA (avg)
0.12
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
0.09
Tax Ratio
28.81%
Dividend Payout Ratio
24.49%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.22%
ROE (avg)
7.40%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.67
EV to EBIT
-63.25
EV to EBITDA
-128.43
EV to Capital Employed
0.66
EV to Sales
9.13
PEG Ratio
0.20
Dividend Yield
2.77%
ROCE (Latest)
-1.04%
ROE (Latest)
8.49%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
PRE-TAX PROFIT(Q)

At CNY 11.5 MM has Grown at 274.35%

ROCE(HY)

Highest at 10.21%

NET PROFIT(Q)

Highest at CNY 1,351.59 MM

EPS(Q)

Highest at CNY 1.05

-11What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 522.59 MM

INTEREST(HY)

At CNY 21.87 MM has Grown at 7.56%

RAW MATERIAL COST(Y)

Grown by 6.28% (YoY

CASH AND EQV(HY)

Lowest at CNY 5,812.7 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.44 times

Here's what is working for Jilin Aodong Pharmaceutical Group Co., Ltd.

Pre-Tax Profit
At CNY 11.5 MM has Grown at 274.35%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 1,351.59 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit
At CNY 1,351.59 MM has Grown at 94.16%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 1.05
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Here's what is not working for Jilin Aodong Pharmaceutical Group Co., Ltd.

Interest
At CNY 21.87 MM has Grown at 7.56%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow
Lowest at CNY 522.59 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Cash and Eqv
Lowest at CNY 5,812.7 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio
Lowest at 1.44 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost
Grown by 6.28% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading